Skip to main content

Table 3 Associations between different kinds of dietary fibre intake and NAFLD by sex a

From: Insoluble dietary fibre intake is associated with lower prevalence of newly-diagnosed non-alcoholic fatty liver disease in Chinese men: a large population-based cross-sectional study

 Categories of dietary fibre intakeP for trend b
All participants (n = 23,529)Level 1Level 2Level 3Level 4 
Soluble dietary fibre
 Adjusted model dRef1.00 (0.88, 1.14) c0.90 (0.78, 1.03)0.91 (0.77, 1.08)0.13
Insoluble dietary fibre
 Adjusted model dRef0.91 (0.79, 1.04)0.86 (0.74, 1.01)0.70 (0.58, 0.85)< 0.001
Men (n = 10,998)Level 1Level 2Level 3Level 4 
Soluble dietary fibre (range, g/d)0.318, 7.3937.394, 10.83810.839, 16.63616.637, 86.605 
 Adjusted model dRef1.00 (0.85, 1.17)0.85 (0.72, 1.02)0.95 (0.78, 1.16)0.54
Insoluble dietary fibre (range, g/d)0.839, 9.3829.384, 12.56112.563, 16.84116.842, 88.567 
 Adjusted model dRef0.86 (0.73, 1.02)0.80 (0.67, 0.97)0.60 (0.47, 0.76)< 0.0001
Women (n = 12,531)Level 1Level 2Level 3Level 4 
Soluble dietary fibre (range, g/d)0.143, 6.7026.703, 9.8749.875, 14.94814.951, 93.307 
 Adjusted model dRef0.98 (0.78, 1.23)0.97 (0.76, 1.23)0.83 (0.62, 1.11)0.16
Insoluble dietary fibre (range, g/d)0.257, 8.7628.765, 11.79811.799, 15.68915.691, 99.987 
 Adjusted model dRef1.00 (0.79, 1.27)0.98 (0.75, 1.29)0.95 (0.68, 1.32)0.72
  1. a NAFLD Non-alcoholic fatty liver disease, CVD Cardiovascular disease, BMI Body mass index, DHA Docosahexaenoic acid, EPA Eicosapentaenoic acid
  2. b Multiple logistic regression analysis
  3. c Odds ratios (95% confidence interval) (all such values)
  4. d Adjusted for age, sex (only for all participants), BMI, type 2 diabetes, hypertension, hyperlipidaemia, physical activity, educational level, household income, smoking status, drinking status, employment status, energy intake (kcal/d), total carbohydrate intake (g/d), total fat intake (g/d), sweet foods intake (g/d), red meat intake (g/d), white meat intake (g/d), DHA + EPA intake (g/d), and family history of CVD, hypertension, and diabetes